Venturi Wealth Management, LLC Hutchmed (China) LTD Transaction History

Venturi Wealth Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$15.52 - $35.65 $115,515 - $265,342	-7,443 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$28.89 - $35.33 $9,938 - $12,153	344 Added 4.85%	7,443 $261,000
Q3 2021 Oct 19, 2021	BUY	$35.66 - $42.94 $16,867 - $20,310	473 Added 7.14%	7,099 $260,000
Q2 2021 Aug 02, 2021	BUY	$23.7 - $39.27 $156,301 - $258,985	6,595 Added 21274.19%	6,626 $260,000
Q3 2019 Oct 29, 2019	BUY	$17.84 - $22.69 $553 - $703	31 New	31 $1,000

6.88M

6.2K

1.1K

Ticker HCM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 172,955,008
Market Cap $2.35B
Description
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...

Get notified when there are updates to the investment portfolio of Venturi Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Venturi Wealth Management, LLC with notifications on news.